参考文献/References:
[1] 中华中医药学会.骨质疏松性骨折中医诊疗指南[J].中医正骨,2023,35(1):1-9.
[2] 中华医学会骨质疏松和骨矿盐疾病分会.原发性骨质疏松症诊疗指南(2017)[J].中国骨质疏松杂志,2019,25(3):281-309.
[3] 卢朝霞,王欣,周少怀.补肾健脾汤对绝经后骨质疏松症患者细胞因子及骨密度水平的影响[J].陕西中医,2017,38(4):438-439.
[4] 王意园,刘斯仪,姜虹会,等.线粒体自噬调节骨重建及药物干预作用的研究进展[J].广西医科大学学报,2024,41(11):1483-1490.
[5] 程婧,魏林,李苗.线粒体动力学及线粒体自噬调控机制的研究进展[J].生理学报,2020,72(4):475-487.
[6] 陈明杏,文皓楠,刘小钰,等.线粒体自噬在绝经后骨质疏松症中的调控机制[J].辽宁中医药大学学报,2025,27(4):209-214.
[7] 付夜平,杨芳,孙鑫,等.补肾健脾法对OP大鼠肌骨中ULK1/FUNDC1介导的线粒体自噬的影响[J].中国骨质疏松杂志,2024,30(7):953-958.
[8] 文晓晨,刘若实,朱克,等.补肾健脾法调控自噬相关PINK1/Parkin信号通路治疗糖尿病性骨质疏松症[J].中国中医基础医学杂志,2025,31(4):649-654.
[9] 米健国,乔荣勤,刘少津.补肾健脾活血方干预骨质疏松模型大鼠骨代谢、氧化应激及自噬的变化[J].中国组织工程研究,2022,26(26):4147-4152.
[10] 黄锴,周大鹏.基于“脾肾互赞”探讨老年性骨质疏松辨治思路[J].实用中医内科杂志,2025,39(5):137-139.
[11] 王岚,王平,邹新蓉,等.从“肾藏精主骨”理论探讨中医药治疗CKD骨-血管轴病变的机理[J].时珍国医国药,2020,31(2):385-387.
[12] 赖依瑶,吴冬梅.基于“阳化气,阴成形”探讨脾肾阳虚型绝经前后诸证的辨治[J].湖北中医杂志,2025,47(5):53-56.
[13] 戴志远,杨浩淼,严寅嘉,等.基于“脾主为卫”理论从脾论治骨质疏松症[J].中医正骨,2024,36(8):66-68.
[14] 孙振双,耿元卿,张丽君,等.氧化应激介导绝经后骨质疏松发病机制的研究进展[J].中国骨质疏松杂志,2016,22(8):1063-1067.
[15] 智信,陈晓,苏佳灿.绝经后骨质疏松症发病机制研究进展[J].中国骨质疏松杂志,2018,24(11):1510-1513.
[16] 邓若尘,房庆城,方睿.绝经后骨质疏松症与氧化应激的相关性研究[J].现代医院,2022,22(2):310-312.
[17] 周俊,胡犇,戢力维,等.中药对线粒体自噬影响的研究进展[J].中国医药导报,2021,18(22):50-54.
[18] 李微,张博,张雨薇,等.雌激素调节骨代谢作用的研究进展[J].中国骨质疏松杂志,2017,23(2):262-266.
[19] 李冠慧,李灿东,李西海,等.雌激素调控绝经后骨质疏松症骨吸收-骨形成耦联失衡的机制[J].中医正骨,2016,28(2):36-40.
[20] 廖秀风,陈叶.基于MicroRNA介导Wnt/β-catenin通路防治绝经后骨质疏松的中西医研究进展[J].现代中西医结合杂志,2019,28(29):3298-3303.
[21] 吕林,王凤云,马祥雪,等.中医脾虚本质科学内涵研究之探讨[J].世界科学技术-中医药现代化,2024,26(3):622-627.
[22] 林海鸣,郑敏麟,阮诗玮,等.水湿困脾证与线粒体的关系研究[J].江西中医药大学学报,2015,27(3):35-38.
[23] 李凤娇,顾雯,俞捷,等.线粒体自噬机制、相关疾病及中药对其调节作用的研究进展[J].中国药房,2018,29(20):2865-2871.
[24] 樊立鹏,孙自学,门波,等.益肾通络方改善精子线粒体膜电位的临床研究[J].中药材,2024,47(6):1553-1556.
[25] 马洪月,宋琳,朴钟源,等.线粒体自噬在临床疾病中的作用及中药对其影响的研究进展[J].中国实验方剂学杂志,2022,28(19):250-257.
[26] 何林熹.中医体质分类辨识及肾阳虚体质线粒体基因SNP研究[D].成都:成都中医药大学,2020.
[27] 黄佳纯,黄宏兴,万雷,等.脾肾-肌骨-线粒体理论探析[J].中国骨质疏松杂志,2021,27(12):1844-1847.
[28] 郝彦宏.线粒体氧化应激在绝经后骨质疏松中的作用机制[D].呼和浩特:内蒙古医科大学,2024.
[29] 郭晛,任艳玲.左、右归丸干预PINK1/Parkin信号通路调控绝经后骨质疏松症自噬的机制[J].中华中医药杂志,2023,38(3):1208-1212.
[30] 李颖,林燕平,黄佳纯,等.补肾健脾活血方调控Apaf-1/CHOP-Caspase-9/Bcl-2通路抑制成骨细胞氧化应激[J].中国骨质疏松杂志,2024,30(5):649-654.
[31] 吴睿哲,吴洁,刘凯,等.基于分子对接及实验验证研究补肾健脾活血方通过Wnt信号通路防治骨质疏松症的作用机制[J].中医药导报,2022,28(8):27-31.
相似文献/References:
[1]李林军.应用膨胀式椎弓根螺钉内固定治疗合并骨质疏松的
胸腰椎退行性疾病[J].中医正骨,2015,27(08):49.
[2]李学朋,朱立国.骨疏康胶囊对去卵巢大鼠骨小梁的影响[J].中医正骨,2015,27(12):12.
LI Xuepeng,ZHU Liguo.Effect of Gushukang Jiaonang(骨疏康胶囊)on bone trabecula in the ovariectomized rats[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(06):12.
[3]陈冠军,陈扬,庄汝杰.可灌注骨水泥椎弓根螺钉系统
在老年腰椎疾患手术中的应用[J].中医正骨,2015,27(02):40.
[4]王丹辉,贲越,韩梅.林蛙油治疗绝经后骨质疏松症的临床研究[J].中医正骨,2014,26(01):27.
Wang Danhui*,Ben Yue,Han Mei..Clinical study of Rana temporaria oil in the treatment of postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(06):27.
[5]黄建华,黄建武,李慧辉,等.加味左归丸对绝经后骨质疏松症肝肾不足证
患者骨密度的影响[J].中医正骨,2013,25(11):19.
Huang Jianhua*,Huang Jianwu,Li Huihui,et al.Effect of JIAWEI ZUOGUI pill on bone mineral density in postmenopausal osteoporosis patients with deficiency of liver and kidney[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2013,25(06):19.
[6]项旻,杨虹,林爱菊,等.绝经后2型糖尿病患者骨质疏松与血微量元素的关系研究[J].中医正骨,2013,25(12):20.
Xiang Min*,Yang Hong,Lin Aiju,et al.Clinical study on the relationship between osteoporosis and serum trace elements levels in postmenopausal women with type 2 diabetes[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2013,25(06):20.
[7]史晓林,李春雯,张志强.弱阳离子磁珠分离技术和基质辅助激光解吸电离飞行时间质谱技术在原发性Ⅰ型骨质疏松症血清标志蛋白筛选中的应用[J].中医正骨,2014,26(03):5.
Shi Xiaolin*,Li Chunwen,Zhang Zhiqiang..Application of magnetic beads based weak cation exchange separation technology and matrix-assisted laser desorption-ionization time of flight mass spectrometry technology in screening serum protein markers of primary type-Ⅰ osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(06):5.
[8]李明,徐明雄,冯左基,等.自拟壮骨方治疗绝经后骨质疏松症的疗效及作用机制研究[J].中医正骨,2014,26(09):21.
Li Ming*,Xu Mingxiong,Feng Zuoji,et al.Study on the curative effect and mechanism of action of self-made ZHUANGGU decoction in treatment of postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(06):21.
[9]陈俊杰,李晴晴,夏瑢.脂代谢及血清内脂素水平与绝经后骨质疏松症的
相关性研究[J].中医正骨,2012,24(04):16.
CHEN Jun-jie*,LI Qing-qing,XIA Rong.*.Study on the correlations between the levels of lipid metabolism and serum visfatin and postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2012,24(06):16.
[10]许超,肖鲁伟,吴承亮.绝经后女性骨质疏松症辨证分型与抑郁焦虑的关系研究[J].中医正骨,2011,23(12):3.
XU Chao*,XIAO Lu-wei,WU Cheng-liang.*.Study on the relationship between the syndrome differ classification and the depression and anxiety for the postmenopausal women with osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2011,23(06):3.
[11]韩艳,温利平,刘娜,等.补肾活血方对去卵巢大鼠骨代谢及骨密度的影响[J].中医正骨,2015,27(12):7.
HAN Yan,WEN Liping,LIU Na,et al.Effect of Bushen Huoxue Fang(补肾活血方)on bone metabolism and bone mineral density in the ovariectomized rats[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(06):7.
[12]欧国峰,刘鑫,董博,等.绝经后骨质疏松症的免疫学研究进展[J].中医正骨,2016,28(08):70.
[13]施振宇,刘钟,陈文亮,等.中医综合疗法防治绝经后骨量减少的多中心临床研究[J].中医正骨,2017,29(04):1.
SHI Zhenyu,LIU Zhong,CHEN Wenliang,et al.A multicenter clinical study of complex therapy of traditional Chinese medicine for prevention and treatment of postmenopausal osteopenia[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2017,29(06):1.
[14]梁文娜,李西海,李灿东.血清microRNA与绝经后骨质疏松症肾虚证的关系[J].中医正骨,2017,29(10):53.
[15]梁文娜,李西海,胡柳,等.二至丸抑制绝经后骨质疏松大鼠骨代谢紊乱的作用机制研究[J].中医正骨,2017,29(11):1.
LIANG Wenna,LI Xihai,HU Liu,et al.Study on mechanism of action of Erzhi Wan(二至丸)in inhibiting bone metabolism disorder in rats with postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2017,29(06):1.
[16]刘晨,李兴勇,姚兴璋,等.绝经后骨质疏松症的流行病学概况及发病机制研究进展[J].中医正骨,2018,30(03):52.
[17]杨依然,刘钟,毛一凡,等.酪蛋白激酶-2相互作用蛋白1基于磷脂酰肌醇3-激酶/蛋白激酶B/哺乳动物雷帕霉素靶蛋白通路参与绝经后骨质疏松症发生发展过程中细胞自噬的机制[J].中医正骨,2018,30(04):59.
[18]曹俊青,郑剑南,张麟.右归丸联合阿仑膦酸钠口服治疗绝经后骨质疏松症肾阳虚证的临床研究[J].中医正骨,2018,30(05):20.
CAO Junqing,ZHENG Jiannan,ZHANG Lin.A clinical study of oral application of Yougui Wan(右归丸)and alendronate sodium for treatment of postmenopausal osteoporosis with kidney-yang deficiency syndrome[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2018,30(06):20.
[19]李中万,徐绍俊,杨广钢,等.健肾方联合碳酸钙D3咀嚼片(Ⅱ)
治疗绝经后骨质疏松症肾阳虚证[J].中医正骨,2018,30(08):11.
LI Zhongwan,XU Shaojun,YANG Guanggang,et al.Oral application of Jianshen Fang(健肾方)and calcium carbonate and Vitamin D3 chewable tablets(Ⅱ)for treatment of postmenopausal osteoporosis with kidney-yang deficiency syndrome[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2018,30(06):11.
[20]赵凡,刘全,吴连国.口服强骨饮联合碳酸钙D3片治疗绝经后骨质疏松症的临床研究[J].中医正骨,2019,31(04):26.
ZHAO Fan,LIU Quan,WU Lianguo.Oral applications of Qianggu Yin(强骨饮)and calcium carbonate and Vitamin D3 tablets for treatment of postmenopausal osteoporosis:a clinical study[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2019,31(06):26.